formoterol fumarate

FDA Drug Profile — formoterol fumarate, Formoterol Fumarate

formoterol fumarate is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand names including formoterol fumarate, Formoterol Fumarate. Available dosage forms: solution, powder.

Drug details

Generic Name
formoterol fumarate
Brand Names
formoterol fumarate, Formoterol Fumarate
Application Number
ANDA215053
Sponsor
Lupin Pharmaceuticals, Inc.
NDC Codes
3
Dosage Forms
SOLUTION, POWDER
Routes
RESPIRATORY (INHALATION)
Active Ingredients
FORMOTEROL FUMARATE

Indications and Usage

1 INDICATIONS AND USAGE Formoterol fumarate inhalation solution is a long-acting beta 2 -adrenergic agonist (beta 2 -agonist) indicated for: • Long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. ( 1.1 ) Important limitations of use: • Formoterol fumarate inhalation solution is not indicated to treat acute deteriorations of chronic obstructive pulmonary disease. ( 1.2 , 5.2 ) •Formoterol fumarate inhalation solution is not indicated to treat asthma. ( 1.2 ) 1.1 Maintenance Treatment of COPD Formoterol fumarate inhalation solution is indicated for the long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. 1.2 Important Limitations of Use Formoterol fumarate inhalation solution is not indicated to treat acute deteriorations of chronic obstructive pulmonary disease [ see WARNINGS AND PRECAUTIONS (5.2) ]. Formoterol fumarate inhalation solution is not indicated to treat asthma. The safety and effectiveness of formoterol fumarate inhalation solution in asthma have not been established.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.